Concepedia

Chris Harbron

CH

26

Publications

1.6K

Citations

21

H-Index

2007

Active since

Affiliations

Roche (United Kingdom)(Current)

AstraZeneca (United Kingdom)

Roche (Switzerland)

University Hospital Schleswig-Holstein

Queen Mary University of London

Chris Harbron is an author at Roche (United Kingdom) specializing in medicine, engineering, and data science.

ORCID

Top concepts

Publications per year

2007–2025

26

Publications

26

Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis

Andreas Kindmark, A Jawaid, Chris Harbron et al. · The Pharmacogenomics Journal · 2007 · 365 citations

, , +17

Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)

Jonathan R. Dry, Sandra Pavey, Christine A. Pratilas et al. · Cancer Research · 2010 · 261 citations · Full text

, , +17

RefPlus: an R package extending the RMA Algorithm

Chris Harbron, Kai‐Ming Chang, Marie C. South · Bioinformatics · 2007 · 87 citations · Full text

Synergistic Effects of p38 Mitogen-Activated Protein Kinase Inhibition with a Corticosteroid in Alveolar Macrophages from Patients with Chronic Obstructive Pulmonary Disease

Jane Armstrong, Chris Harbron, Simon Lea et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 85 citations

The use of external controls: To what extent can it currently be recommended?

Hans Ulrich Burger, Christoph Gerlinger, Chris Harbron et al. · Pharmaceutical Statistics · 2021 · 84 citations · Full text

, , +17

Rows per page

1–5 of 26